My Quote Request
No products added yet
6505-01-165-6208
20 Products
K-1
POTASSIUM ACETATE,USP
NSN, MFG P/N
6505011656208
NSN
6505-01-165-6208
MFG
ORGANON INC ORGANON TEKNIKA CORP SUB OF AKZONE INC
Description
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 11.800 GRAMS
PRIMARY CONTAINER TYPE: PACKET
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
267
DIGOXIN CAPSULES
NSN, MFG P/N
6505011651484
NSN
6505-01-165-1484
MFG
BURROUGHS WELLCOME CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS DIGOXIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIGOXIN CAPSULES 0.1MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
LANOXICAPS
DIGOXIN CAPSULES
NSN, MFG P/N
6505011651484
NSN
6505-01-165-1484
MFG
BURROUGHS WELLCOME CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS DIGOXIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIGOXIN CAPSULES 0.1MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00081-0272-55
DIGOXIN CAPSULES
NSN, MFG P/N
6505011651484
NSN
6505-01-165-1484
MFG
BURROUGHS WELLCOME CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS DIGOXIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIGOXIN CAPSULES 0.1MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00173-0272-55
DIGOXIN CAPSULES
NSN, MFG P/N
6505011651484
NSN
6505-01-165-1484
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 MILLIGRAMS DIGOXIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIGOXIN CAPSULES 0.1MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
8368
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011651542
NSN
6505-01-165-1542
8368
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011651542
NSN
6505-01-165-1542
MFG
NATIONAL MEDICAL CARE MEDICAL PRODUCTS DIV INC DBA ERIKA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 GRAMS DEXTROSE PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 134.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 37.000 MEQ ACETATE ION PER LITER; 1.500 MEQ MAGNESIUM ION PER LITER; AND 2.000 POTASSIUM ION PER LITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 3430.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION TO 34 PARTS WATER
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
ERI-LYTE 120P
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011651542
NSN
6505-01-165-1542
ERI-LYTE 120P
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011651542
NSN
6505-01-165-1542
MFG
NATIONAL MEDICAL CARE MEDICAL PRODUCTS DIV INC DBA ERIKA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 GRAMS DEXTROSE PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 134.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 37.000 MEQ ACETATE ION PER LITER; 1.500 MEQ MAGNESIUM ION PER LITER; AND 2.000 POTASSIUM ION PER LITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 3430.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION TO 34 PARTS WATER
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
NDC00052-0813-25
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505011654470
NSN
6505-01-165-4470
NDC00052-0813-25
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505011654470
NSN
6505-01-165-4470
MFG
ORGANON INC ORGANON DIAGNOSTICS SUB OF AKZONA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20000.000 USP UNITS HEPARIN SODIUM PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00467-1155-25
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505011654470
NSN
6505-01-165-4470
NDC00467-1155-25
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505011654470
NSN
6505-01-165-4470
MFG
INVENEX LABORATORIES LIFE TECHNOLOGIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20000.000 USP UNITS HEPARIN SODIUM PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00469-1155-15
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505011654470
NSN
6505-01-165-4470
NDC00469-1155-15
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505011654470
NSN
6505-01-165-4470
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20000.000 USP UNITS HEPARIN SODIUM PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
ACID MANTLE CREME
ALUMINUM ACETATE CREAM
NSN, MFG P/N
6505011654954
NSN
6505-01-165-4954
ACID MANTLE CREME
ALUMINUM ACETATE CREAM
NSN, MFG P/N
6505011654954
NSN
6505-01-165-4954
MFG
SANDOZ CONSUMER HEALTH CARE GROUP
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: NOT FOR OPHTHALMIC USE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SANDOZ
Related Searches:
NDC00043-0904-01
ALUMINUM ACETATE CREAM
NSN, MFG P/N
6505011654954
NSN
6505-01-165-4954
NDC00043-0904-01
ALUMINUM ACETATE CREAM
NSN, MFG P/N
6505011654954
NSN
6505-01-165-4954
MFG
SANDOZ CONSUMER HEALTH CARE GROUP
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
SPECIAL FEATURES: NOT FOR OPHTHALMIC USE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SANDOZ
Related Searches:
NDC00083-2025-26
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505011655655
NSN
6505-01-165-5655
NDC00083-2025-26
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505011655655
NSN
6505-01-165-5655
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 12.5MG ADHESIVE BANDAGE 30S PG
OVERALL STRENGTH IN SYSTEM: 12.5 MG NITROGLYCERIN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION
SYSTEM SIZE: 5 SQUARE CENTIMETER
USUAL DOSE: 0.1 MG RELEASED PER HOUR
Related Searches:
NDC57267-0902-42
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505011655655
NSN
6505-01-165-5655
NDC57267-0902-42
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505011655655
NSN
6505-01-165-5655
MFG
CIBA-GEIGY CORP SUMMIT PHARMACEUTICALS DIV
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 12.5MG ADHESIVE BANDAGE 30S PG
OVERALL STRENGTH IN SYSTEM: 12.5 MG NITROGLYCERIN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION
SYSTEM SIZE: 5 SQUARE CENTIMETER
USUAL DOSE: 0.1 MG RELEASED PER HOUR
Related Searches:
TRANSDERM-NITRO
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505011655655
NSN
6505-01-165-5655
TRANSDERM-NITRO
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505011655655
NSN
6505-01-165-5655
MFG
CIBA-GEIGY CORP SUMMIT PHARMACEUTICALS DIV
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 12.5MG ADHESIVE BANDAGE 30S PG
OVERALL STRENGTH IN SYSTEM: 12.5 MG NITROGLYCERIN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION
SYSTEM SIZE: 5 SQUARE CENTIMETER
USUAL DOSE: 0.1 MG RELEASED PER HOUR
Related Searches:
NDC00083-2115-26
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505011655656
NSN
6505-01-165-5656
NDC00083-2115-26
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505011655656
NSN
6505-01-165-5656
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 75MG 15MG RELEASED/24 HOURS 30S
OVERALL STRENGTH IN SYSTEM: 75 MG NITROGLYCERIN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION
SYSTEM SIZE: 30 SQUARE CENTIMETER
USUAL DOSE: 0.6 MG RELEASED PER HOUR
Related Searches:
NDC57267-0915-42
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505011655656
NSN
6505-01-165-5656
NDC57267-0915-42
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505011655656
NSN
6505-01-165-5656
MFG
CIBA-GEIGY CORP SUMMIT PHARMACEUTICALS DIV
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 75MG 15MG RELEASED/24 HOURS 30S
OVERALL STRENGTH IN SYSTEM: 75 MG NITROGLYCERIN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION
SYSTEM SIZE: 30 SQUARE CENTIMETER
USUAL DOSE: 0.6 MG RELEASED PER HOUR
Related Searches:
TRANSDERM-NITRO
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505011655656
NSN
6505-01-165-5656
TRANSDERM-NITRO
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505011655656
NSN
6505-01-165-5656
MFG
CIBA-GEIGY CORP SUMMIT PHARMACEUTICALS DIV
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 75MG 15MG RELEASED/24 HOURS 30S
OVERALL STRENGTH IN SYSTEM: 75 MG NITROGLYCERIN ACTIVE INGREDIENT
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION
SYSTEM SIZE: 30 SQUARE CENTIMETER
USUAL DOSE: 0.6 MG RELEASED PER HOUR
Related Searches:
5030
ATROPINE SULFATE AND NEOSTIGMINE METHYLSULFATE FOR INJECTION
NSN, MFG P/N
6505011656206
NSN
6505-01-165-6206
5030
ATROPINE SULFATE AND NEOSTIGMINE METHYLSULFATE FOR INJECTION
NSN, MFG P/N
6505011656206
NSN
6505-01-165-6206
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.200 MILLIGRAMS ATROPINE SULFATE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS NEOSTIGMINE METHYLSULFATE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 3.500 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CLOSED SYSTEM CONTAINING DRY POWDER AND 3.5 MILLILITERS DILUENT; 21 GAGE BY 1-1/2 INCH NEEDLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00548-5030-00
ATROPINE SULFATE AND NEOSTIGMINE METHYLSULFATE FOR INJECTION
NSN, MFG P/N
6505011656206
NSN
6505-01-165-6206
NDC00548-5030-00
ATROPINE SULFATE AND NEOSTIGMINE METHYLSULFATE FOR INJECTION
NSN, MFG P/N
6505011656206
NSN
6505-01-165-6206
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.200 MILLIGRAMS ATROPINE SULFATE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS NEOSTIGMINE METHYLSULFATE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 3.500 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CLOSED SYSTEM CONTAINING DRY POWDER AND 3.5 MILLILITERS DILUENT; 21 GAGE BY 1-1/2 INCH NEEDLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
